1. Cancer-specific SNPs originate from low-level heteroplasmic variants in human mitochondrial genomes of a matched cell line pair
    Annica Hedberg et al, 2019, Mitochondrial DNA Part A CrossRef
  2. Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action
    Baptiste Jouffre et al, 2023, Scientific Reports CrossRef
  3. Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system
    Chaw Yee Beh et al, 2019, PLOS ONE CrossRef
  4. Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction
    Nataša Debeljak et al, 2014, Frontiers in Immunology CrossRef
  5. Overexpression of the erythropoietin receptor in RAMA 37 breast cancer cells alters cell growth and sensitivity to tamoxifen
    Lenka Ilkovičová et al, 2017, International Journal of Oncology CrossRef
  6. Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo
    Mei Hong et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
  7. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation
    Susann Reinbothe et al, 2014, Biochemical and Biophysical Research Communications CrossRef
  8. Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells
    Nina Trost et al, 2013, Radiology and Oncology CrossRef
  9. The Effect of Erythropoietin on Progesterone Levels during Ischemia Reperfusion Injury in Rats
    Constantinos Tsompos et al, 2014, Journal of South Asian Federation of Obstetrics and Gynaecology CrossRef
  10. Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells
    Guan-Young Teo et al, 2020, Saudi Journal of Biological Sciences CrossRef
  11. Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma
    Takafumi Minami et al, 2014, International Immunopharmacology CrossRef
  12. Erythropoietin Induces an Epithelial to Mesenchymal Transition-Like Process in Mammary Epithelial Cells MCF10A
    Alejandra Ordoñez-Moreno et al, 2017, Journal of Cellular Biochemistry CrossRef
  13. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer
    Eliana Vanina Elias et al, 2016, Oncotarget CrossRef
  14. Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells
    Barbora Fecková et al, 2019, BMC Genetics CrossRef
  15. The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
    Marko Hojnik et al, 2023, International Journal of Molecular Sciences CrossRef